Staar Surgical Company

NASDAQ: STAA
$32.38
+$2.41 (+8.0%)
Closing Price on September 13, 2024

STAA Chart and Intraday Price

STAA Company Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry OPHTHALMIC GOODS
Address 1911 WALKER AVE, MONROVIA, CA, US
Fiscal Year End January
Latest Quarter 1/31/2024
Market Cap 1,627.72M USD
Shares Outstanding 48,865,900
Staar Surgical Company specializes in creating and distributing implantable lenses for the eye, aiming to correct visual disorders like myopia, hyperopia, astigmatism, and presbyopia. Their innovative Collamer lens products are marketed to healthcare professionals, including ophthalmic surgeons and vision centers, across the globe. With a strong presence in the United States, Japan, and Europe, Staar Surgical leverages both direct sales teams and independent distributors to reach its market. Founded in 1982 and based in Lake Forest, California, the company is a key player in the eye care industry.

STAA Articles

New Year's Insider Buying Focuses on Biotechs
As the year got underway, biotechs were in focus among the notable insider buying, especially in two companies focused on treatments for the eye.
Trey Thoelcke
Published:

See Which Inside Buyers Are Scooping Up More Shares Now
Some of the biggest insider buying since the Thanksgiving holiday has come from repeat buyers, including Bill Ackman, who continues to build his stake in a real estate firm.
Trey Thoelcke
Published:

Friday's Top Wall Street Analyst Upgrades and Downgrades: Etsy, Moderna, Qualcomm, Roku, Ross Stores, Royal Caribbean, Southwest Airlines, Wayfair and More
Friday's top analyst upgrades and downgrades included DXC Technology, Etsy, Extreme Networks, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines,...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: ADT, Aurora Cannabis, CarMax, Skechers, Tesla, Tilray and More
Thursday's top analyst upgrades and downgrades included ADT, Aurora Cannabis, CarMax, Shift4 Payments, Skechers USA, Tesla and Tilray.
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Adobe, AMD, Bank of New York, Carlyle, Chewy, CVS Health, Fifth Third Bancorp, Luminar, Nike, Pinterest, Walgreens and More
Tuesday's top analyst upgrades and downgrades included Adobe, Advanced Micro Devices, Bank of New York Mellon, Carlyle, CF Industries, Chewy, Cleveland-Cliffs, CVS Health, Fifth Third Bancorp,...
Lee Jackson
Published:

Monday's Top Analyst Upgrades and Downgrades: American Express, BlackBerry, FedEx, MGM Resorts, Nike, Warby Parker and More
Monday's top analyst upgrades and downgrades included American Express, BlackBerry, FedEx, Garmin, Manchester United, MGM Resorts, Nike, Omnicom, TransUnion and Warby Parker.
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: American Express, Cloudera, Diamondback Energy, Discover Financial, GM, UnitedHealth and More
Friday's top analyst upgrades and downgrades included American Express, Bumble, Cloudera, Diamondback Energy, Discover Financial, General Motors, Match, NOV and UnitedHealth.
Lee Jackson
Published:

Why 4 Jefferies Franchise List Stocks Could Be Big Second-Half Winners
These four Jefferies stock picks in the health care space offer outstanding upside potential for investors long term and look like very solid ideas for the rest of 2021, especially with an overbought...
Lee Jackson
Published:

Jefferies Makes Huge Summer Changes to Franchise List of Top Stock Picks
Three outstanding stocks have joined the Jefferies Franchise Picks in a sizable portfolio change, as the analysts see a profound shift as the pandemic continues to abate and the reopening prospects...
Lee Jackson
Published: